Latest News

{{header-clinical-trials-navigation}} Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy in the Management of Gleason Group 5 Prostate Cancer Condition: Prostate Cancer, Prostate Disease Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT03543189 Sponsor: H. Lee Moffitt Cancer Center and Research Institute Phase: Phase 1/Phase 2 Eligibility: Age: minimum 18 Years maximum N/A […]

{{header-clinical-trials-navigation}} A Multicenter, Open-Label, Exploratory Platform Study to Evaluate Biomarkers and Immunotherapy Combinations for the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer Condition: Metastatic Castration-resistant Prostate Cancer Study Type: Interventional Clinical Trials Identifier NCT 8-digits: NCT03835533 Sponsor: Parker Institute for Cancer Immunotherapy Phase: Phase 1 Eligibility: Age: minimum 18 Years maximum N/A Gender: Male […]

To examine the efficacy of perineal urethrostomy (PU) in patients with anterior urethral stricture. Patients who underwent PU for anterior urethral stricture between 2013 and 2020 were retrospectively reviewed (n = 56).

The objective was to identify incidence and risk factors of de novo urgency and detrusor overactivity (DO) following mid-urethral slings (MUS) in patients with urodynamic stress incontinence (USI) without urgency.

The urogenital microbiome is associated with urgency and mixed urinary incontinence symptoms and differential treatment response to pharmacotherapy for urgency urinary incontinence. To describe whether the preoperative urinary and vaginal microbiomes were associated with treatment response 12-months after mid-urethral sling surgery in women with mixed urinary incontinence.

Male stress urinary incontinence (SUI) following prostate treatment is a devastating complaint for many patients. While the artificial urinary sphincter is the gold standard treatment for male SUI, the urethral sling is also popular due to ease of placement, lack of mechanical complexity, and absence of manual dexterity requirement.

To perform a cost-effectiveness analysis for the surgical and non-surgical management of stress urinary incontinence (SUI) with and without the availability of midurethral sling. Cost-effectiveness analysis.

Symptoms of male overactive bladder (OAB) may be caused by several systemic pathophysiological factors rather than a single-source etiology. We investigated the clinical factors associated with the severity of OAB symptoms in treatment-naïve men with coexisting benign prostatic hyperplasia.

This article aims to explore changes in urinary concentrations of selected neurotrophins in the course of TENS therapy in children with overactive bladder (OAB). A two-group open-label prospective study was conducted.

Neurogenic overactive bladder is a main feature of human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis. We successfully performed intravesical onabotulinumtoxinA therapy for refractory neurogenic overactive bladder due to human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.